USD 0.04
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 201.78 Thousand USD | -94.53% |
2022 | 3.68 Million USD | 839.87% |
2021 | 392.19 Thousand USD | 2.51% |
2020 | 382.6 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | - USD | -100.0% |
2024 Q1 | 166.23 Thousand USD | -17.62% |
2023 Q3 | - USD | -100.0% |
2023 FY | 201.78 Thousand USD | -94.53% |
2023 Q4 | 201.78 Thousand USD | 0.0% |
2023 Q2 | 3.56 Million USD | 2.94% |
2023 Q1 | 3.46 Million USD | -6.13% |
2022 Q2 | 2 Million USD | 0.0% |
2022 Q1 | - USD | -100.0% |
2022 FY | 3.68 Million USD | 839.87% |
2022 Q4 | 3.68 Million USD | 81.18% |
2022 Q3 | 2.03 Million USD | 1.48% |
2021 FY | 392.19 Thousand USD | 2.51% |
2021 Q2 | 393.89 Thousand USD | 0.0% |
2021 Q4 | 392.19 Thousand USD | 19.8% |
2021 Q3 | 327.36 Thousand USD | -16.89% |
2021 Q1 | - USD | -100.0% |
2020 Q4 | 382.6 Thousand USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 FY | 382.6 Thousand USD | 0.0% |
2019 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
BioQuest Corp. | - USD | -Infinity% |
Clever Leaves Holdings Inc. | 720 Thousand USD | 71.975% |
Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 99.641% |
Guardion Health Sciences, Inc. | - USD | -Infinity% |
GSRX Industries Inc. | - USD | -Infinity% |
High Sierra Technologies, Inc. | 50 Thousand USD | -303.566% |
Instadose Pharma Corp. | - USD | -Infinity% |